Sodium Bicarbonate → (R)-3-[2-fluoro-4-(piperazine-1-carbonyl)phenyl]-4-methoxymethyloxazolidin-2-one
反応式
C(OC([N:8]1[CH2:13][CH2:12][N:11]([C:14](=[O:31])[C:15]2[CH:20]=[CH:19][C:18]([N:21]3[C@H:25]([CH2:26][O:27][CH3:28])[CH2:24][O:23][C:22]3=[O:29])=[C:17]([F:30])[CH:16]=2)[CH2:10][CH2:9]1)=O)(C)(C)C.Cl.C(OCC)(=O)C.C(=O)([O-])O.[Na+]>C(OCC)(=O)C>[F:30][C:17]1[CH:16]=[C:15]([C:14]([N:11]2[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]2)=[O:31])[CH:20]=[CH:19][C:18]=1[N:21]1[C@H:25]([CH2:26][O:27][CH3:28])[CH2:24][O:23][C:22]1=[O:29]参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
(R)-4-[3-Fluoro-4-(4-methoxymethyl-2-oxooxazolidin-3-yl)benzoyl]piperazine-1-carboxylic acid tert-butyl ester (506 mg) described in Preparation Example 93 was dissolved in ethyl acetate (5 mL), 4N hydrogen chloride/ethyl acetate (5 mL) was added and the mixture was stirred at room temperature. Under ice-cooling, the reaction mixture was neutralized with ethyl acetate and saturated aqueous sodium hydrogen carbonate solution, and extracted once with ethyl acetate and the aqueous layer was extracted with twice with chloroform. The organic layer was dried over sodium sulfate and the solvent was evaporated under reduced pressure to give the title compound (390 mg).
後処理
- temperatureUnder ice-cooling
- extractionextracted once with ethyl acetate
- extractionthe aqueous layer was extracted with twice with chloroform
- dry with materialThe organic layer was dried over sodium sulfate
- customthe solvent was evaporated under reduced pressure
出典と根拠
- ORDレコード
- ord-51b2e81de1a74df5b02afdb6d60c1568
- 出典データセット
- uspto-grants-2013_01
- 特許番号
- US08354401B2
反応ノート
読み込み中…